指南与共识乳腺癌放疗

乳房切除术后放疗:ASTRO/ASCO/SSO临床实践指南

Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline.
指南 / 共识 · Pract Radiat Oncol · 2025-09-16

该指南由ASTRO、ASCO和SSO组建多学科工作组,基于系统文献综述,针对乳房切除术后放疗(PMRT)的适应证、靶区与剂量分割、治疗技术共4个关键问题给出循证推荐。推荐涵盖 upfront手术与和新辅助系统治疗后场景,并明确中等大分割优选、CT三维适形计划及深呼吸屏气等技术要点。

要点

  • upfront乳房切除术后,多数淋巴结阳性及部分淋巴结阴性患者有PMRT指征。
  • 新辅助系统治疗后,局部晚期或手术时残留淋巴结病变者推荐PMRT。
  • PMRT时照射同侧胸壁/重建乳房及区域淋巴引流区,优选中等大分割。

核心结论

  • 该指南为乳腺癌乳房切除术后放疗提供循证推荐,指导PMRT的适应证、靶区、剂量分割与技术选择。

研究设计与样本

  • ASTRO、ASCO和SSO组建多学科工作组,基于系统文献综述和预设共识方法及证据质量分级系统制定推荐。

主要发现

  • upfront乳房切除术后,PMRT适用于多数淋巴结阳性乳腺癌患者和选择性淋巴结阴性患者。
  • 新辅助系统治疗后,对局部晚期初诊患者和手术时残留淋巴结病变者推荐PMRT。
  • 新辅助系统治疗后病理淋巴结阴性(ypN0)的cT1-3N1或cT3N0乳腺癌患者,有条件推荐PMRT。
  • PMRT时推荐照射同侧胸壁/重建乳房和区域淋巴引流区,优选中等大分割,常规分割仅在罕见情况可接受。
  • 推荐CT为基础的三维适形放疗计划,三维适形无法达到治疗目标时建议调强放疗,并推荐深呼吸屏气技术保护正常组织。

关键数值与推荐

  • PMRT指照射胸壁和同侧区域淋巴结,包括高危腋窝、锁骨上下及内乳淋巴结。
  • 皮肤受侵、浅表切缘阳性或淋巴血管侵犯患者推荐使用bolus,但不推荐常规使用组织等效bolus。

临床怎么用

  • 临床应依据指南推荐的适应证选择PMRT,优先采用中等大分割和CT三维适形计划,并合理使用深呼吸屏气及bolus。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This guideline provides evidence-based recommendations on the use of postmastectomy radiation therapy (PMRT) in the treatment of breast cancer. PMRT refers to the treatment of the chest wall and ipsilateral regional nodes, including at-risk axillary, supra/infraclavicular, and internal mammary nodes. Updated recommendations detail indications for PMRT in the upfront surgical setting and after neoadjuvant systemic therapy, and provide guidance on appropriate target volumes, dosing, and treatment techniques. METHODS: The American Society for Radiation Oncology, American Society of Clinical Oncology, and the Society of Surgical Oncology convened a multidisciplinary task force to address 4 key questions focused on radiation therapy (RT) in patients with breast cancer who undergo mastectomy including (1) indications for PMRT after upfront surgery, (2) indications for PMRT after neoadjuvant systemic therapy followed by surgery, (3) appropriate PMRT treatment volumes and dose-fractionation regimens, and (4) treatment techniques. Recommendations were based on a systematic literature review and created using a predefined consensus-building methodology and system for quality of evidence grading and strength of recommendation. RESULTS: After upfront mastectomy, PMRT is indicated for most patients with node-positive breast cancer and select patients with node-negative disease. PMRT is also recommended after neoadjuvant systemic therapy, both for patients presenting with locally advanced disease and for those with residual nodal disease at the time of surgery. PMRT is conditionally recommended for patients with cT1-3N1 or cT3N0 breast cancer with pathologically negative nodes after neoadjuvant systemic therapy (ypN0). When PMRT is delivered, treatment to the ipsilateral chest wall/reconstructed breast and regional lymphatics is recommended, with moderate hypofractionation preferred, but with conventional fractionation approaches acceptable in rare cases. Computed tomography-based volumetric treatment planning with 3-dimensional conformal RT is recommended, with intensity modulated RT advised when 3-dimensional conformal RT is unable to achieve treatment goals. Deep inspiration breath hold techniques are also recommended for normal tissue sparing. For patients with skin involvement, positive superficial margins, and/or lymphovascular invasion, the use of a bolus is recommended, but the routine use of tissue-equivalent bolus is not recommended. CONCLUSIONS: These evidence-based recommendations guide clinical practice on the use of PMRT in patients with breast cancer.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Jimenez RB, Abdou Y, Anderson P, et al. Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline. Pract Radiat Oncol. 2025. PMID: 40956255. doi:10.1016/j.prro.2025.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。